Western blot analysis of antibody specificities in subacute sclerosing panencephalitis: reactivity to measles virus proteins produced in persistently infected cells. 1991

S J Robbins, and J H Pope, and T B Sculley
Sir Albert Sakzewski Virus Research Laboratory, Royal Children's Hospital, Herston, Queensl., Australia.

The specificity of serum antibodies from patients with subacute sclerosing panencephalitis (SSPE) and seropositive controls to measles virus proteins produced in acutely and persistently infected human cells was examined by western blot analysis. Sera from both SSPE patients and controls reacted to the H, N, and F1 virus proteins produced in acutely infected AV3 cells. However, while SSPE-derived sera reacted with the same proteins in persistently infected cells (AV3Al/MV), most control sera failed to react with the hemagglutinin protein produced in such cells (Hp). Most sera also reacted poorly with the M protein from either source, and the reactivity to the P protein was variable. Although the exact reason(s) for the different reactivities to the proteins were not determined, differences in antibody concentration did not appear to be responsible. The dramatic differences in the reactivity of SSPE and control sera to the Hp protein suggest that either the protein coevolves in persistent infections or multiple forms of the protein evolve in such infections and SSPE patients develop broad-spectrum humoral immunity as a consequence of exposure to them. Alternatively, over time there may be selective loss of some H-reactive antibody subsets by individuals who contract measles, but do not develop SSPE.

UI MeSH Term Description Entries
D008459 Measles virus The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children. Edmonston virus
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D013344 Subacute Sclerosing Panencephalitis A rare, slowly progressive encephalitis caused by chronic infection with the MEASLES VIRUS. The condition occurs primarily in children and young adults, approximately 2-8 years after the initial infection. A gradual decline in intellectual abilities and behavioral alterations are followed by progressive MYOCLONUS; MUSCLE SPASTICITY; SEIZURES; DEMENTIA; autonomic dysfunction; and ATAXIA. DEATH usually occurs 1-3 years after disease onset. Pathologic features include perivascular cuffing, eosinophilic cytoplasmic inclusions, neurophagia, and fibrous gliosis. It is caused by the SSPE virus, which is a defective variant of MEASLES VIRUS. (From Adams et al., Principles of Neurology, 6th ed, pp767-8) Encephalitis, Inclusion Body, Measles,Leukoencephalitis, Subacute Sclerosing,Measles Inclusion Body Encephalitis,Panencephalitis, Subacute Sclerosing,SSPE,Van Bogaert's Leukoencephalitis,Inclusion Body Encephalitis, Measles,Leukoencephalitis, Van Bogaert's,Sclerosing Leukoencephalitis, Subacute,Sclerosing Panencephalitis, Subacute,Leukoencephalitides, Subacute Sclerosing,Leukoencephalitis, Van Bogaert,Leukoencephalitis, Van Bogaerts,Panencephalitides, Subacute Sclerosing,Sclerosing Leukoencephalitides, Subacute,Sclerosing Panencephalitides, Subacute,Subacute Sclerosing Leukoencephalitides,Subacute Sclerosing Leukoencephalitis,Subacute Sclerosing Panencephalitides,Van Bogaert Leukoencephalitis,Van Bogaerts Leukoencephalitis

Related Publications

S J Robbins, and J H Pope, and T B Sculley
January 1977, Archives of virology,
S J Robbins, and J H Pope, and T B Sculley
June 1977, Lancet (London, England),
S J Robbins, and J H Pope, and T B Sculley
March 1967, Lancet (London, England),
S J Robbins, and J H Pope, and T B Sculley
December 1981, Japanese journal of medical science & biology,
S J Robbins, and J H Pope, and T B Sculley
January 1968, Science (New York, N.Y.),
S J Robbins, and J H Pope, and T B Sculley
September 2022, Clinical laboratory,
S J Robbins, and J H Pope, and T B Sculley
October 1973, Annals of clinical research,
S J Robbins, and J H Pope, and T B Sculley
January 1990, Microbiology and immunology,
S J Robbins, and J H Pope, and T B Sculley
April 1979, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!